Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Fred Hutch scientists make important step in identifying specific T cells to fight against cancer

Novel antiviral drug can protect transplant patients against CMV infections

Novel antiviral drug can protect transplant patients against CMV infections

Scientists devise novel DNA vaccine approach against important cancer antigen targets

Scientists devise novel DNA vaccine approach against important cancer antigen targets

MSK researchers harness power of CRISPR/Cas9 to create more-potent CAR T cells

MSK researchers harness power of CRISPR/Cas9 to create more-potent CAR T cells

Research: Biomaterials that mimic bone marrow can alter blood cell development

Research: Biomaterials that mimic bone marrow can alter blood cell development

Essen Bioscience to Showcase IncuCyte® Live-cell Analysis System and Applications at AACR, Booth #1365

Essen Bioscience to Showcase IncuCyte® Live-cell Analysis System and Applications at AACR, Booth #1365

Researchers show how metabolism drives proliferation of tumor cells

Researchers show how metabolism drives proliferation of tumor cells

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Targeting tumor suppressor protein could be effective treatment for some AML patients, study suggests

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Young adults, adolescents with acute leukemia treated at specialized cancer centers have higher survival rates

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

Researchers create novel model that reveals cellular, molecular events driving leukemia progression

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

UMass Amherst study highlights unmet drug needs of patients with rare diseases

UMass Amherst study highlights unmet drug needs of patients with rare diseases

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

Salk professor receives inaugural Sjöberg Prize for groundbreaking cancer research

Scientists aim to create data mining tools to identify personalized treatment options for cancer

Scientists aim to create data mining tools to identify personalized treatment options for cancer

Professor aims to develop shortcuts for targeted and effective cancer therapy

Professor aims to develop shortcuts for targeted and effective cancer therapy

New drug offers hope for patients with bladder cancer

New drug offers hope for patients with bladder cancer

Researchers develop computer machine-learning model to predict remission or relapse in AML patients

Researchers develop computer machine-learning model to predict remission or relapse in AML patients

Genetic profiling of blood cells can predict response to stem cell transplant for patients with MDS

Genetic profiling of blood cells can predict response to stem cell transplant for patients with MDS

Scientists identify vulnerabilities of highly aggressive pancreatic cancer cells

Scientists identify vulnerabilities of highly aggressive pancreatic cancer cells

Study suggests that iPSCs do not develop more mutations than subcloned cells

Study suggests that iPSCs do not develop more mutations than subcloned cells